Baltera Robert Jr. 4

What Happened
Robert Baltera Jr., a director of Palisade Bio, purchased a total of 30,000 common shares in two open-market transactions. He bought 20,000 shares on 2026-07-01 for $1.98 per share (total $39,600) and 10,000 shares on 2026-07-02 for $1.98 per share (total $19,800), for an aggregate cost of approximately $59,400. These were purchases (code P), which are generally viewed as insider buying rather than selling.

Key Details

• Transaction dates and amounts:
  • 2026-07-01: 20,000 shares acquired at a weighted average $1.98 (≈ $39,600)
  • 2026-07-02: 10,000 shares acquired at a weighted average $1.98 (≈ $19,800)
• Aggregate: 30,000 shares acquired for ≈ $59,400.
• Footnote: reported price is a weighted average; actual trade prices ranged from $1.97 to $1.99. The filer will provide a breakdown on request (Footnote F1).
• Filing: Form 4 filed 2026-07-06 covering the 2026-07-01 and 2026-07-02 transactions; this appears to be within normal Section 16 filing timing (filed within the expected business-day window).
• Shares owned after the transactions: not specified in the provided filing details.

Context
These were straightforward open-market purchases (no option exercise, award, or gift involved). Purchases by directors can be of interest to retail investors as a signal that an insider is adding to their position, but they do not prove future performance. The amounts here are modest (~$59.4k total).